Pharmacosmos
Manufacturing · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
120 Headquarters Plz Fl 6, Morristown, N...Phone Number
(908) 769-7100Website
www.pharmacosmos.usRevenue
$40.5 MillionIndustry
About Pharmacosmos
Pharmacosmos Therapeutics Inc. is a United States specialty pharmaceutical company and the American affiliate of Denmark-based Pharmacosmos, a family-owned international healthcare company founded in 1965. The company specializes in the treatment of iron deficiency and iron deficiency anemia, focusing primarily on the prescription iron pharmaceutical market which represents two-thirds of its revenue. Pharmacosmos Therapeutics commercializes Monoferric, a high-dose intravenous iron treatment marketed in the United States, and provides exceptional resources to support patient care. The parent company Pharmacosmos is recognized as a global pioneer in carbohydrate chemistry and a world leader in iron therapy, with corporate headquarters, manufacturing facilities, and research laboratories located in Holbaek, Denmark. The company develops, manufactures, and markets medicines for treating iron deficiency anemia in humans and animals, while also specializing in developing and producing advancRead more
SIC Code 28,283NAICS Code 32,325Show morePharmacosmos Org Chart
Pharmacosmos Tech Stack
A closer look at the technologies used by Pharmacosmos
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pharmacosmos
Sign Up For FreeTo access detailed company insights
Pharmacosmos Therapeutics Inc. is a United States specialty pharmaceutical company and the American affiliate of Denmark-based Pharmacosmos, a family-owned international healthcare company founded in 1965. The company specializes in the treatment of iron deficiency and iron deficiency anemia, focusing primarily on the prescription iron pharmaceutic... Read More